Thus, the administration of MSE may be effective for preventing and/or treating obesity and its associated metabolic complications by promoting APN multimerization via DsbA-L, although further human studies in obese/overweight subjects are needed to verify these findings. Here, ANPEP is linked to obesity due to melanocortin 4 receptor deficiency.